CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-06 | Ellis Ronald J. Jr. Chief Strategy Officer | Sale | −1,114 | $38.99 | $43K | 32,071 |
| 2023-06-05 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Sale 10b5-1 | −2,267 | $38.28 | $87K | 17,398 |
| 2023-06-05 | HASTINGS PAUL J Director | Sale | −580 | $38.34 | $22K | 6,599 |
| 2023-06-05 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −1,000 | $38.74 | $39K | 23,591 |
| 2023-06-05 | Brege Laura Director | Sale 10b5-1 | −600 | $38.74 | $23K | 9,547 |
| 2023-05-31 | GAUGLER DARYL Chief Operating Officer | Option exercise 10b5-1 | +2,500 | $34.00 | $85K | 26,894 |
| 2023-05-31 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −2,500 | $39.08 | $98K | 24,591 |
| 2023-05-31 | GAUGLER DARYL Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 0 | ||
| 2023-05-15 | HASTINGS PAUL J Director | Option exercise 10b5-1 | +7,000 | $29.90 | $209K | 14,179 |
| 2023-05-15 | HASTINGS PAUL J Director | Sale 10b5-1 | −7,000 | $41.85 | $293K | 7,179 |
| 2023-05-15 | HASTINGS PAUL J Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,000 | 0 | ||
| 2023-05-11 | PACE GARY W Director | Option exercise | +7,000 | $29.90 | $209K | 144,690 |
| 2023-05-11 | PACE GARY W Director | Sale | −5,015 | $41.78 | $210K | 139,675 |
| 2023-05-11 | PACE GARY W Director | Option exercise · Stock Option (Right to Buy) | −7,000 | 0 | ||
| 2023-04-03 | Brege Laura Director | Option exercise 10b5-1 | +7,000 | $29.90 | $209K | 17,147 |
| 2023-04-03 | Brege Laura Director | Sale 10b5-1 | −7,000 | $40.72 | $285K | 10,147 |
| 2023-04-03 | Brege Laura Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,000 | 0 | ||
| 2023-01-05 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Sale | −546 | $38.31 | $21K | 19,450 |
| 2023-01-04 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Sale | −158 | $39.09 | $6K | 19,996 |
| 2022-10-07 | REINHARDT MAX President, Rest of World | Sale | −1,380 | $58.00 | $80K | 31,378 |
Page 12 of 23 · 450 trades